POSTER SESSION II Monday, February 28, 2005   —  1:00 - 4:30 PM Convention Center, Exhibit Hall B PATHOLOGY OF LIVER & PANCREAS 146 Increased Bax/Bcl-2 Ratio Upregulates Caspase-3 and Increases Apoptosis in an Experimental Model of Acute Liver Failure (1298) C Kalogeropoulou, I Tsota, P Zabakis, T Kourelis, T Petsas, AC Tsamandas - Univ. of Patras, Greece 147 Liver Cell Steatosis and Apoptosis in Experimental Fatty Liver Disease. A Mechanism towards Increased Liver Injury (1297) C Kalogeropoulou, I Tsota, P Zabakis, T Kourelis, T Petsas, AC Tsamandas - Univ. of Patras, Patras, Greece 148 Histologic Variation of Grade and Stage of Non-Alcoholic Fatty Liver Disease in Liver Biopsies Obtained from Obese Patients during Gastric Bypass Surgery (1295) ER Jacobson, DJ Janiec, L Spaulding, H Blaszyk - University of Vermont College of Medicine, Burlington, VT; Walter Reed Army Medical Center, Washington, DC 149 The Expression of PDGF-C in Non-Alcoholic Steatohepatitis: A Trend of Increase as Fibrosis Progresses and a Pattern of Centrilobular Accentuation (1322) AJ Shaw, JS Campbell, N Fausto, J Dai, MM Yeh - University of Washington, Seattle, WA 150 Resistance of Fatty Acyl-CoA Oxidase Null Mice to Methionine-Choline Deficient Diet-Induced Steatohepatitis (1299) P Kashireddy, R Gupta, MS Rao - Feinberg School of Medicine, Northwestern University, Chicago, IL 151 Stellate Cell Activation in Liver Biopsies with Hepatitis C Compared with Hepatitis C/Diabetes Mellitus (1317) M Rivera, F Ahmed, LM Petrovic - NYPH-Weill Cornell Medical Center, New York, NY 152 Correlation of Laboratory Values, Genotypes and Liver Histology in Hepatitis C (1327) SS Talwalkar, L Zhang, J Snyder, C Maclein, MB Ray - Univ. of Louisville, Louisville, KY 153 Correlation of Hepatitis B Surface Antigen and Hepatitis B Core Antigen Immunohistochemical Stains with Serum HBV DNA and ALT in Patients with Chronic HBV (1268) A Auerbach, A Mehrotra, Z Goodman, D Apelian, R Wilber - The Armed Forces Institute of Pathology, Washington, DC; Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 154 Correlation between Hereditary Hemochromatosis Genotypes and Phenotypes (1340) MM Yearsley, I Aguilera, WL Frankel, TW Prior - The Ohio State University Medical Center, Columbus, OH 155 Copper Stain in Chronic Biliary Disease: An Aid To Diagnosis? (1316) H Qureshi, SC Abraham, TC Smyrk - Mayo Clinic, Rochester, MN 156 Clinicopathologic Findings and Outcome for 12 Liver Transplants with Unusual Donor Diseases (1306) M Krishna, S Pungpapong, SC Abraham, AP Keaveny, RC Dickson, RE Nakhleh - Mayo Clinic, Jacksonville, FL; Mayo Clinic, Rochester, MN 157 Prevalence and Significance of Central Venulitis in Adult Liver Allografts (1305) AM Krasinskas, SC Abraham - University of Pittsburgh Medical Center, Pittsburgh, PA; Mayo Clinic, Rochester, MN 158 Diffuse Biliary Casts Causing Hepatic Allograft Failure: Clinicopathological Perspective (1296) S Jakate, J Scudiere, A Savo, F Dodson - Rush University Medical Center, Chicago, IL 159 Evaluation of Interobserver Agreement in Hepatitis C Grading/Staging and ACR Grading: The "HCV 3" Multiinstitutional Trial Experience (1315) GJ Netto, G Klintmalm, The Hepatitis C 3 Trial Group - Baylor University Medical Ctr., Dallas, TX 160 Impact of MELD (Model for End-Stage Liver Disease) Scoring System on Findings at and after Liver Transplantation (LT) (1269) G Azabdaftari, M Simpson, E Pomfret, J Pomposelli, W Lewis, F Gordon, R Jenkins, U Khettry - Brigham and Women's Hosp, Harvard Med Sch, Boston, MA; Lahey Clinic Med Ctr, Tufts Univ Sch of Med, Burlington, MA 161 Plasma Cell Infiltrate May Predict the Severity of Acute Cellular Rejection in Liver Allografts (1282) W Chu, PE Swanson, MP Upton, MM Yeh - University of Washington Medical Center, Seattle, WA 162 Reticulin, Copper, and CD34 Staining in the Diagnosis of Focal Nodular Hyperplasia (1326) ZL Tabatabai, LD Ferrell - University of California San Francisco, San Francisco, CA 163 Hepatic Angiomyolipomas Share a Similar Gene Expression Profile with Hepatic Stellate Cells (1330) M Torbenson, R Kannangai, M Rojkind, J Sicklick, AM Diehl - Johns Hopkins, Baltimore, MD; George Washington University, Washington, DC; Duke University Medical Center, Durham, NC 164 Expression of BNIP3, a Pro-Apoptotic Protein, Is Suppressed during Hepatic Carcinogenesis (1336) R Wilcox, K Tracy, B Dibling, M Tretiakova, K Macleod, J Hart - University of Chicago 165 EGFR Is Phosphorylated at Ty845 in Hepatocellular Carcinoma (1331) M Torbenson, R Kannangai, F Sahin - Johns Hopkins, Baltimore, MD 166 Telomere Shortening in Hepatocellular Carcinomas Arising in Cirrhotic Livers in Patients Infected with Hepatitis C Virus (1300) P Kashireddy, DM Weinrach, KL Wang, MS Rao - The Feinberg School of Medicine, Northwestern University, Chicago, IL 167 The Role of Matrix Metalloproteinases and Their Inhibitors in the Metastatic Potential of Primary Hepatic Tumors (1332) M Tretiakova, Z Gao, W Liu, C Gong, J Hart - University of Chicago, Chicago, IL; University of Calgary, Calgary, AB, Canada 168 Association of E-Cadherin, Matrix Metalloproteinases, and Tissue Inhibitors of Metalloproteinases in the Progression of Hepatocellular Carcinoma (1288) Z Gao, M Tretiakova, W Liu, J Hart - University of Calgary, Calgary, AB, Canada; University of Chicago, Chicago, IL 169 Demonstration of Metallothionein in Hepatocellular Carcinomas and Hepatocellular Adenomas - A Molecular and Immunohistochemical Analysis (1287) CC Gable, K Ghoshal, S Majumder, ST Jacob, ML Prasad, WL Frankel - The Ohio State University, Columbus, OH 170 Under-Expression of JUNB Gene in Hepatocellular Carcinoma (1280) JH Chang, YS Chang, KT Yeh, JG Chang - Chang-Hua Christian Hospital, Chang-Hua, Taiwan; China Medical College, Taichung, Taiwan 171 Hepatic Progenitor Cell Activation in Human Chronic Liver Diseases and the Relation to Hepatocellular Carcinoma Development (1334) AC Tsamandas, D Dimitropoulou, I Syrrokosta, T Kourelis, D Bonikos, C Gogos - Univ. of Patras, Greece 172 Monocyte Recruitment and Modulation of Angiogenesis in Hepatocellular Carcinoma (1341) LM Yerian, MW Lingen - Cleveland Clinic Foundation, Cleveland, OH; University of Chicago, Chicago, IL 173 Incidental Hepatocellular Carcinomas Arising in Hepatitis C Cirrhosis - A Study of Liver Explants (1267) A Arslan, M Facciuto, G Ramaswamy - Westchester Medical Center, Valhalla, NY 174 a - Methylacyl Coenzyme A Racemase (P504S Antibody) Expression in Hepatocellular Carcinoma (1328) K Taylor, D Lawson, G Cotsonis, A Fields, C Cohen - Emory University School of Medicine and Emory University School of Public Health, Atlanta, GA 175 Overexpression of ß-Catenin is Associated with the Progression of Human Hepatocarcinogenesis Independent of GSK-3 beta (1308) J Liang, M Losada, L Barisoni, L Chiriboga, H Yee, B West - New York University Medical Center, New York, NY 176 Hepatocellular Carcinoma: Therapeutic Intervention and Outcome - A Pathology Perspective (1276) N Buza, F Regenstein, S Dash, S Haque - National Institute of Oncology, Budapest, Hungary; Tulane University Health Sciences Center, New Orleans, LA 177 Activated Caspase 3 Expression in Hepatocellular Carcinoma (1329) K Taylor, D Lawson, G Cotsonis, A Fields, C Cohen - Emory University School of Medicine and Emory University School of Public Health, Atlanta, GA